JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CZOO
5601
DELISTED
Cazoo Group Ltd
CZOO
| $32K | ﹤0.01% |
127
+125
| +6,250% | +$40.7K |
2021 Q4
5 quarters
|
|
|
YELL
5602
DELISTED
Yellow Corporation Common Stock
YELL
| $32K | ﹤0.01% |
15,778
-126,563
| -89% | -$337K |
2021 Q1
8 quarters
|
|
5603
Amplify AI Powered Equity ETF
AIEQ
$115M
| $31K | ﹤0.01% |
1,060
+760
| +253% | +$23K |
2020 Q3
10 quarters
|
|
5604
BlackRock Resources & Commodities Strategy Trust
BCX
$907M
| $31K | ﹤0.01% |
+3,223
| New | +$32.1K |
2023 Q1
0 quarters
|
|
5605
Nuveen California AMT-Free Quality Municipal Income Fund
NKX
$586M
| $31K | ﹤0.01% |
+2,686
| New | +$32.4K |
2023 Q1
0 quarters
|
|
5606
Praxis Precision Medicines
PRAX
$7.92B
| $31K | ﹤0.01% |
2,533
+1,008
| +66% | +$42.5K |
2020 Q4
9 quarters
|
|
5607
iShares MSCI India Small-Cap ETF
SMIN
$725M
| $31K | ﹤0.01% |
615
-3,780
| -86% | -$193K |
2021 Q1
8 quarters
|
|
|
ASXC
5608
DELISTED
Asensus Surgical, Inc.
ASXC
| $31K | ﹤0.01% |
+47,114
| New | +$31.9K |
2023 Q1
0 quarters
|
|
|
CURO
5609
DELISTED
CURO Group Holdings Corp.
CURO
| $31K | ﹤0.01% |
17,833
-19,070
| -52% | -$62K |
2018 Q1
20 quarters
|
|
5610
American Realty Investors
ARL
$255M
| $30K | ﹤0.01% |
1,155
+130
| +13% | +$3.31K |
2018 Q2
19 quarters
|
|
5611
Celularity
CELU
$55.5M
| $30K | ﹤0.01% |
4,879
+1,257
| +35% | +$10.1K |
2022 Q2
3 quarters
|
|
|
FARM
5612
DELISTED
Farmer Brothers
FARM
| $30K | ﹤0.01% |
7,671
-1,539
| -17% | -$6.95K |
2013 Q2
39 quarters
|
|
5613
Invesco CurrencyShares Australian Dollar Trust
FXA
$93.1M
| $30K | ﹤0.01% |
+454
| New | +$30.7K |
2023 Q1
0 quarters
|
|
5614
Garrett Motion
GTX
$4.98B
| $30K | ﹤0.01% |
3,861
-9,830
| -72% | -$76.1K |
2021 Q2
7 quarters
|
|
5615
Lulu's Fashion Lounge
LVLU
$35.6M
| $30K | ﹤0.01% |
850
+222
| +35% | +$9.39K |
2021 Q4
5 quarters
|
|
5616
Ondas Inc
ONDS
$4.32B
| $30K | ﹤0.01% |
27,707
+7,508
| +37% | +$13.1K |
2022 Q2
3 quarters
|
|
5617
CALL
Paycom
PAYC
$10.2B
| $30K | ﹤0.01% |
100
-900
| -90% | -$271K |
2021 Q3
6 quarters
|
|
|
KRNLU
5618
DELISTED
Kernel Group Holdings, Inc. Units
KRNLU
| $30K | ﹤0.01% |
+2,925
| New | +$30K |
2023 Q1
0 quarters
|
|
|
TARO
5619
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $30K | ﹤0.01% |
1,222
+305
| +33% | +$8.89K |
2015 Q4
29 quarters
|
|
|
GRNA
5620
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
| $30K | ﹤0.01% |
69,130
+18,180
| +36% | +$14K |
2022 Q1
4 quarters
|
|
5621
Invesco S&P 500 Momentum ETF
SPMO
$23.3B
| $29.2K | ﹤0.01% |
+536
| New | +$29.4K |
2023 Q1
0 quarters
|
|
|
MGF
5622
Aberdeen Government Markets Income Fund
MGF
$87.7M
| $29K | ﹤0.01% |
+8,691
| New | +$28.9K |
2023 Q1
0 quarters
|
|
5623
CALL
Shell
SHEL
$275B
| $29K | ﹤0.01% |
+500
| New | +$29.4K |
2023 Q1
0 quarters
|
|
5624
WhiteHorse Finance
WHF
$152M
| $29K | ﹤0.01% |
2,343
+781
| +50% | +$10.2K |
2022 Q4
1 quarter
|
|
|
YSG
5625
Yatsen Holding
YSG
$242M
| $29K | ﹤0.01% |
3,861
-3,090
| -44% | -$23.2K |
2021 Q4
5 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.